These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 37301747
1. Silencing of PKG1 Gene Mimics Effect of Aging and Sensitizes Rat Vascular Smooth Muscle Cells to Cardiotonic Steroids: Impact on Fibrosis and Salt Sensitivity. Fedorova OV, Shilova VY, Zernetkina V, Juhasz O, Wei W, Lakatta EG, Bagrov AY. J Am Heart Assoc; 2023 Jun 20; 12(12):e028768. PubMed ID: 37301747 [Abstract] [Full Text] [Related]
2. Age-associated increase in salt sensitivity is accompanied by a shift in the atrial natriuretic peptide modulation of the effect of marinobufagenin on renal and vascular sodium pump. Fedorova OV, Kashkin VA, Zakharova IO, Lakatta EG, Bagrov AY. J Hypertens; 2012 Sep 20; 30(9):1817-26. PubMed ID: 22796708 [Abstract] [Full Text] [Related]
4. Atrial natriuretic peptide and cGMP inhibit Na+/H+ antiporter in vascular smooth muscle cells in culture. Caramelo C, López-Farré A, Riesco A, Olivera A, Okada K, Cragoe EJ, Tsai P, Briner VA, Schrier RW. Kidney Int; 1994 Jan 20; 45(1):66-75. PubMed ID: 8127023 [Abstract] [Full Text] [Related]
5. TNF-α elicits phenotypic and functional alterations of vascular smooth muscle cells by miR-155-5p-dependent down-regulation of cGMP-dependent kinase 1. Choi S, Park M, Kim J, Park W, Kim S, Lee DK, Hwang JY, Choe J, Won MH, Ryoo S, Ha KS, Kwon YG, Kim YM. J Biol Chem; 2018 Sep 21; 293(38):14812-14822. PubMed ID: 30104414 [Abstract] [Full Text] [Related]
16. Effect of Cardiotonic Steroid Marinobufagenin on Vascular Remodeling and Cognitive Impairment in Young Dahl-S Rats. Grigorova YN, Juhasz O, Long JM, Zernetkina VI, Hall ML, Wei W, Morrell CH, Petrashevskaya N, Morrow A, LaNasa KH, Bagrov AY, Rapp PR, Lakatta EG, Fedorova OV. Int J Mol Sci; 2022 Apr 20; 23(9):. PubMed ID: 35562955 [Abstract] [Full Text] [Related]
17. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism. Bagrov AY, Dmitrieva RI, Dorofeeva NA, Fedorova OV, Lopatin DA, Lakatta EG, Droy-Lefaix MT. J Hypertens; 2000 Feb 20; 18(2):209-15. PubMed ID: 10694190 [Abstract] [Full Text] [Related]
18. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor. Hirata Y, Matsuoka H, Suzuki E, Hayakawa H, Sugimoto T, Matsuda Y, Morishita Y, Kangawa K, Minamino N, Matsuo H. Circulation; 1993 Feb 20; 87(2):554-61. PubMed ID: 8381060 [Abstract] [Full Text] [Related]
19. Down-regulation of protein kinase C potentiates atrial natriuretic peptide-stimulated cGMP accumulation in vascular smooth-muscle cells. Kawabe J, Ohsaki Y, Onodera S. Biochim Biophys Acta; 1992 Dec 15; 1175(1):81-7. PubMed ID: 1362357 [Abstract] [Full Text] [Related]
20. Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase. Scavone C, Scanlon C, McKee M, Nathanson JA. J Pharmacol Exp Ther; 1995 Mar 15; 272(3):1036-43. PubMed ID: 7891313 [Abstract] [Full Text] [Related] Page: [Next] [New Search]